Jason Aryeh - Director at Ligand Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jason Aryeh - trading volume in the past year for Ligand Pharmaceuticals Inc

Holdings reported by Jason Aryeh for Ligand Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69.3K $11.9M $171.92 Sep 23, 2025 Direct
Common Stock 51.6K $7.79M $151.08 Sep 23, 2025 Indirect
Common Stock 5.03K $759K $151.08 Sep 23, 2025 by Trust
Non-Qualified Stock Option (right to buy) 5.78K Jun 6, 2025 Direct Common Stock

Transactions reported by Jason Aryeh for Ligand Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.